Published in J Theor Biol on May 01, 1966
Familial renal glycosuria: a genetic reappraisal of hexose transport by kidney and intestine. J Clin Invest (1969) 1.11
Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med (1981) 6.76
Economic foundations of cost-effectiveness analysis. J Health Econ (1997) 3.33
An apple a day. A futuristic parable. N Engl J Med (1994) 2.71
Policy options and the impact of national health insurance. N Engl J Med (1974) 2.50
The association between interdisciplinary collaboration and patient outcomes in a medical intensive care unit. Heart Lung (1992) 2.47
Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem (1988) 1.90
An inborn defect in the metabolism of tyrosine in infants on a normal diet. Biochem J (1960) 1.60
Mass screening of the newborn for metabolic disease. Arch Dis Child (1968) 1.43
Cryotherapy in infants with retinopathy of prematurity. A decision model for treating one or both eyes. JAMA (1989) 1.38
Women in American medicine. J Med Educ (1968) 1.36
Genetics of phenylketonuria. Heterozygosity for phenylketonuria. Nature (1967) 1.20
Price elasticity and adverse selection in the demand for supplementary health insurance. Econ Inq (1987) 1.19
The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group. Arch Neurol (1994) 1.10
The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care (1997) 1.07
Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia? Commun Psychopharmacol (1978) 1.02
The isolation and properties of phenylalanine hydroxylase from human liver. Biochem J (1974) 1.00
Death and taxes. An opportunity for substitution. J Health Econ (1988) 0.97
The isolation and properties of phenylalanine hydroxylase from rat liver. Biochem J (1974) 0.96
Perspectives in health economics. Health Econ (1996) 0.95
Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man. Nature (1971) 0.95
The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group. JAMA (1993) 0.95
Metabolism of phenylalanine in mice homozygous for the gene 'dilute lethal'. Biochem J (1970) 0.93
A third allele at the phenylalanine-hydroxylase locus in mild phenylketonuria (hyperphenylalaninaemia). Lancet (1968) 0.93
Policy options and the impact of national health insurance. J Calif Dent Assoc (1974) 0.91
Decreased urinary output of tyramine and its metabolites in depression. Br J Psychiatry (1978) 0.91
Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med (1994) 0.91
Impaired gluconeogenesis in dogs with E. coli bacteremia. Surgery (1974) 0.90
Birth weight and pathogenesis in phenylketonuria. Int J Neurosci (1990) 0.89
The heterozygote advantage in phenylketonuria. Am J Hum Genet (1986) 0.88
Induced demand--can we ever know its extent? J Health Econ (1986) 0.87
Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers. Am J Prev Med (1994) 0.86
Phenylketonuria as a balanced polymorphism: the nature of the heterozygote advantage. Ann Hum Genet (1975) 0.86
Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. Clin Chim Acta (1979) 0.86
Gas chromatographic assay of phenylacetic acid in biological fluids. Clin Chim Acta (1975) 0.86
The non-enzymic hydroxylation of phenylalanine to tyrosine by 2-amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine. Biochem J (1971) 0.86
Regulatory intensity and hospital cost growth. J Health Econ (1990) 0.85
Efficacy of isatin analogues as antagonists of rat brain and heart atrial natriuretic peptide receptors coupled to particulate guanylyl cyclase. Biochem Pharmacol (1999) 0.84
Caffeine ingestion and breast cancer. A negative correlation. Cancer (1988) 0.84
A study of the cause of the high incidence of phenylketonuria in Ireland and west Scotland. Ir Med J (1976) 0.84
Major operative trauma increases peripheral amino acid release during the steady-state infusion of total parenteral nutrition in man. Surgery (1986) 0.84
Deficient production of tyramine and octopamine in cases of depression. Nature (1979) 0.83
The isolation, properties, and assay of phenylalanine hydroxylase from human and rat liver. Biochem Med (1976) 0.83
The dietary treatment of phenylketonuria: not proven. Dev Med Child Neurol (1967) 0.83
Krabbe's leukodystrophy without globoid cells. Neurology (1976) 0.83
Late onset phenylalanine intoxication. J Inherit Metab Dis (1980) 0.82
Trace amine deficit in depressive illness: the phenylalanine connexion. Acta Psychiatr Scand Suppl (1980) 0.82
Tyrosinosis (inborn hepato-renal dysfunction). Proc R Soc Med (1966) 0.82
Gas chromatographic estimation of urinary homovanillic and 4-hydroxy-3-methoxymandelic acids using capillary columns. Clin Chim Acta (1974) 0.82
Illness prevention and medical insurance. J Hum Resour (1978) 0.82
Amino acid metabolism in patients with severe burns. Surgery (1982) 0.81
Conference on sex ratio in phenylketonuria. J Pediatr (1971) 0.80
Femoral arteriovenous amino acid differences in septic patients. Surgery (1979) 0.80
The high frequency of phenylketonuria in Ireland and Western Scotland. J Inherit Metab Dis (1978) 0.80
Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment. Psychopharmacology (Berl) (1988) 0.79
Phenylacetic acid in human cerebrospinal fluid and plasma: selected ion monitoring assay. Biomed Mass Spectrom (1978) 0.79
Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. J Neural Transm (1986) 0.79
Arterial plasma amino acids in patients with serious postoperative infection and in patients with major fractures. Surgery (1976) 0.78
Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values. J Neurol Neurosurg Psychiatry (1982) 0.78
Recent studies on galactosaemia, phenylketonuria and homocystinuria. Proc Nutr Soc (1968) 0.78
Multiple forms of monoamine oxidase: some in vivo correlations. Adv Biochem Psychopharmacol (1974) 0.77
Adoption and diffusion of a new imaging technology: a magnetic resonance imaging prospective. AJR Am J Roentgenol (1984) 0.77
Metabolism of branched-chain amino acids in dogs with Escherichia coli endotoxin shock. Surgery (1983) 0.76
Isosalsolinol formation: a secondary reaction in the Pictet-Spengler condensation. J Pharm Pharmacol (1974) 0.76
Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness. Psychopharmacology (Berl) (1979) 0.76
Amino acid metabolism in dogs with E. coli bacteremic shock. Surgery (1979) 0.76
A specific assay for urinary 5-hydroxyindole-3-acetic acid by gas chromatography. Clin Chim Acta (1975) 0.76
Increasing the scientific quality of clinical efficacy studies of magnetic resonance imaging. Invest Radiol (1991) 0.75
Comment on Hellinger's "Substitutability Among Different Types of Care Under Medicare". Health Serv Res (1978) 0.75
Phenylketonuria: a reassessment of screening by napkin test. Br Med J (1967) 0.75
Birth weight in phenylketonuria. Arch Dis Child (1995) 0.75
Paediatric screening for genetically determined metabolic diseases. Proc R Soc Med (1968) 0.75
Hydroxylation of p-hydroxyphenylpyruvate and the N I H shift: a hypothesis. Biochem J (1971) 0.75
Phenylketonuria and its variants. West J Med (1979) 0.75
Decreased conjugated tyramine output in depression: the effect of oral L-cysteine. Br J Clin Pharmacol (1980) 0.75
Reduction in birth weight in phenylketonuria. Eur J Pediatr (1997) 0.75
A welfare-based approach to analyzing markets and mergers. J Health Econ (1989) 0.75
Urinary excretion of 0-tyramine. Clin Chim Acta (1974) 0.75
The dietary treatment of inborn errors of metabolism. Proc Nutr Soc (1976) 0.75
NHI won't control costs, quality, or access. Hosp Prog (1977) 0.75
Improved resolution using capillary columns. Clin Chim Acta (1975) 0.75
Specific gas chromatographic measurement of urinary 3,4-dihydroxyphenylacetic acid. Clin Chim Acta (1975) 0.75
Targeting assessments of magnetic resonance imaging in suspected multiple sclerosis. Med Decis Making (1990) 0.75
Arterial plasma amino acids in patients receiving an elemental diet. Surg Forum (1974) 0.75
Variation of levodopa metabolism with gastrointestinal absorption site. Lancet (1974) 0.75
Estimation of branched-chain alpha-keto acids in blood by gas chromatography. J Chromatogr (1982) 0.75
Brain lipids of mice homozygous for the gene 'dilute lethal' (d). J Neurochem (1971) 0.75
Genetics of phenylketonuria. Third allele at the phenylalanine hydroxylase locus in man. Nature (1967) 0.75
Arterial plasma amino acids during the first week following femoral shaft fracture. J Trauma (1979) 0.75
Iminoglycinuria--a "harmless" inborn error of metabolism? Humangenetik (1968) 0.75
Policy options and the impact of national health insurance revisited. Int J Health Serv (1977) 0.75
Sex ratio in phenylketonuria. Lancet (1970) 0.75
Inhibition of arylpyruvate oxidase by chelating agents. Experientia (1973) 0.75
Hereditary tubular disorders. Monogr Pathol (1979) 0.75
Loss of catecholamine derivatives during gas-liquid chromatography. Clin Chim Acta (1973) 0.75
Metatyramine as a dopaminergic agonist. Adv Neurol (1975) 0.75
Splenic lipids in Gaucher's disease. J Lipid Res (1968) 0.75
Arterial plasma amino acids in patients with severe burns. Surgery (1978) 0.75